Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00506077
Show Display Options
Download search resultsDownload the search results for:
NCT00506077 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed
Has Results
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)
Condition: Paranoid Schizophrenia
Interventions: Drug: MK0249;   Drug: Comparator: Placebo (unspecified)

Study has passed its completion date and status has not been verified in more than two years.